Thursday, 20 March 2014

Precision Oncology 3.0

The emerging paradigm of Precision Oncology 3.0 uses panomics (genomic, transcriptomic, proteomic, metabolomic, etc.) and sophisticated methods of statistical reverse engineering to hypothesise the putative networks that drive a given patient's tumour, and to attack the tumour drivers with combinations of targeted therapies. Read more here.

No comments:

Post a Comment